{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:30:27Z","timestamp":1655339427602},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T00:00:00Z","timestamp":1296172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00347-010-2262-0","type":"journal-article","created":{"date-parts":[[2011,1,26]],"date-time":"2011-01-26T14:00:32Z","timestamp":1296050432000},"page":"230-236","source":"Crossref","is-referenced-by-count":5,"title":["Antiangiogene Therapie am vorderen Augenabschnitt"],"prefix":"10.1007","volume":"108","author":[{"given":"F.","family":"Bock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Regenfu\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,28]]},"reference":[{"key":"2262_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archopht.126.1.71","volume":"126","author":"Bachmann","year":"2008","unstructured":"Bachmann B, Bock F, Wiegand S et al (2008) Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol 126:71\u201377","journal-title":"Arch Ophthalmol"},{"key":"2262_CR2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/bjo.2008.145128","volume":"93","author":"Bachmann","year":"2009","unstructured":"Bachmann BO, Luetjen-Drecoll E, Bock F et al (2009) Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation. Br J Ophthalmol 93:1075\u20131080","journal-title":"Br J Ophthalmol"},{"key":"2262_CR3","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","volume":"117","author":"Bachmann","year":"2010","unstructured":"Bachmann B, Taylor RS, Cursiefen C (2010) Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Ophthalmology 117:1300\u20131305","journal-title":"Ophthalmology"},{"key":"2262_CR4","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","volume":"48","author":"Bock","year":"2007","unstructured":"Bock F, Onderka J, Dietrich T et al (2007) Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci 48:2545\u20132552","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2262_CR5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","volume":"246","author":"Bock","year":"2008","unstructured":"Bock F, K\u00f6nig Y, Kruse FE et al (2008) Bevacizumab (Avastin\u00ae) eye drops inhibit corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol 246:281\u2013284","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2262_CR6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nm1078","volume":"10","author":"Chen","year":"2004","unstructured":"Chen L, Hamrah P, Cursiefen C et al (2004) Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) mediates dendritic cell migration to lymph nodes and induction of immunity to corneal transplants. Nat Med 10:813\u2013815","journal-title":"Nat Med"},{"key":"2262_CR7","first-page":"2127","volume":"43","author":"Cursiefen","year":"2002","unstructured":"Cursiefen C, Schl\u00f6tzer-Schrehardt U, K\u00fcchle M et al (2002) Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and Podoplanin. Invest Ophthalmol Vis Sci 43:2127\u20132135","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2262_CR8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00003226-200210000-00003","volume":"21","author":"Cursiefen","year":"2002","unstructured":"Cursiefen C, Martus P, Nguyen NX et al (2002) Corneal neovascularization after nonmechanical versus mechanical corneal trephination for non-high-risk keratoplasty. Cornea 21:648\u2013652","journal-title":"Cornea"},{"key":"2262_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","volume":"87","author":"Cursiefen","year":"2003","unstructured":"Cursiefen C, Rummelt C, K\u00fcchle M, Schl\u00f6tzer-Schrehardt U (2003) Pericyte recruitment in human corneal angiogenesis. Br J Ophthalmol 87:101\u2013106","journal-title":"Br J Ophthalmol"},{"key":"2262_CR10","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"Cursiefen","year":"2004","unstructured":"Cursiefen C, Chen L, Borges L et al (2004) Via bone marrow-derived macrophages, VEGF A mediates lymph- and hemangiogenesis in inflammatory neovascularization. Eur J Clin Invest 113:1040\u20131050","journal-title":"Eur J Clin Invest"},{"key":"2262_CR11","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","volume":"45","author":"Cursiefen","year":"2004","unstructured":"Cursiefen C, Maruyama K, Liu Y et al (2004) Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 45:2666\u20132673","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2262_CR12","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","volume":"103","author":"Cursiefen","year":"2006","unstructured":"Cursiefen C, Chen L, Saint-Geniez M et al (2006) Nonvascular VEGFR3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci U S A 103:11405\u201311410","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2262_CR13","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","volume":"116","author":"Cursiefen","year":"2009","unstructured":"Cursiefen C, Bock F, Horn FK et al (2009) GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. Ophthalmology 116:1630\u20131637","journal-title":"Ophthalmology"},{"key":"2262_CR14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/jimmunol.0903180","volume":"184","author":"Dietrich","year":"2010","unstructured":"Dietrich T, Bock F, Yuen D et al (2010) Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol 184:535\u2013539","journal-title":"J Immunol"},{"key":"2262_CR15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ophtha.2009.06.057","volume":"117","author":"Heindl","year":"2010","unstructured":"Heindl LM, Hofmann T, Adler W et al (2010) Intraocular tumor-associated lymphangiogenesis: a novel prognostic factor for ciliary body melanomas with extraocular extension? Ophthalmology 117:334\u2013342","journal-title":"Ophthalmology"},{"key":"2262_CR16","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1167\/iovs.08-2935","volume":"50","author":"Heindl","year":"2009","unstructured":"Heindl LM, Hofmann TN, Knorr HL et al (2009) Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Invest Ophthalmol Vis Sci 50:1988\u20131995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2262_CR17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/ICU.0b013e3283360aad","volume":"21","author":"Horsley","year":"2010","unstructured":"Horsley MB, Kahook MY (2010) Anti-VEGF therapy for glaucoma. Curr Opin Ophthalmol 21:112\u2013117","journal-title":"Curr Opin Ophthalmol"},{"key":"2262_CR18","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1167\/iovs.07-1314","volume":"49","author":"Hos","year":"2008","unstructured":"Hos D, Bock F, Dietrich T et al (2008) Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation. Invest Ophthalmol Vis Sci 49:1836\u20131842","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2262_CR19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","volume":"247","author":"Koenig","year":"2009","unstructured":"Koenig Y, Bock F, Horn F et al (2009) Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 247:1375\u20131382","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2262_CR20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00417-002-0496-5","volume":"240","author":"K\u00fcchle","year":"2002","unstructured":"K\u00fcchle M, Cursiefen C, Nguyen NX et al (2002) Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol 240:580\u2013584","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2262_CR21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00347-009-1936-y","volume":"106","author":"Leippi","year":"2009","unstructured":"Leippi S, Grehn F, Geerling G (2009) Antiangiogenic therapy for pterygium recurrence. Ophthalmologe 106:413\u2013419","journal-title":"Ophthalmologe"},{"key":"2262_CR22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajo.2007.03.028","volume":"144","author":"Nguyen","year":"2007","unstructured":"Nguyen NX, Seitz B, Martus P et al (2007) Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. Am J Ophthalmol 144:318\u2013319","journal-title":"Am J Ophthalmol"},{"key":"2262_CR23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1167\/iovs.09-4407","volume":"51","author":"Peebo","year":"2010","unstructured":"Peebo BB, Fagerholm P, Traneus-R\u00f6ckert C, Lagali N (2010) Cellular-level characterization of lymph vessels in live, unlabeled corneas by in vivo confocal microscopy. Invest Ophthalmol Vis Sci 51:830\u2013835","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2262_CR24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/lrb.2008.6348","volume":"6","author":"Regenfuss","year":"2008","unstructured":"Regenfuss B, Bock F, Parthasarathy A, Cursiefen C (2008) Corneal (lymph)angiogenesis \u2013 from bedside to bench and back: a tribute to Judah Folkman. Lymphat Res Biol 6:191\u2013201","journal-title":"Lymphat Res Biol"},{"key":"2262_CR25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bjo.2008.147355","volume":"93","author":"Zimmermann","year":"2009","unstructured":"Zimmermann P, Dietrich T, Bock F et al (2009) Tumor-associated lymphangiogenesis in conjunctival malignant melanoma. Br J Ophthalmol 93:1529\u20131534","journal-title":"Br J Ophthalmol"},{"key":"2262_CR26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00347-007-1512-2","volume":"104","author":"Bock","year":"2007","unstructured":"Bock F, K\u00f6nig Y, Dietrich T et al (2007) Inhibition of angiogenesis in the anterior chamber of the eye. Ophthalmologe 104:336\u2013344","journal-title":"Ophthalmologe"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-010-2262-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-010-2262-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-010-2262-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:51:02Z","timestamp":1559051462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-010-2262-0"}},"subtitle":["Wann? Was? Wof\u00fcr?"],"short-title":[],"issued":{"date-parts":[[2011,1,28]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["2262"],"URL":"https:\/\/doi.org\/10.1007\/s00347-010-2262-0","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,28]]}}}